Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Daniel P. Gold
|
| gptkbp:collaboratesWith |
gptkb:Kyowa_Kirin
|
| gptkbp:developedBy |
oncology drugs
|
| gptkbp:focusesOn |
cancer therapeutics
|
| gptkbp:foundedYear |
2000
|
| gptkbp:hasCompany |
true
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
MEI Pharma
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
pracinostat
voruciclib zandelisib |
| gptkbp:stockSymbol |
MEIP
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.meipharma.com/
|
| gptkbp:bfsParent |
gptkb:Sorrento_Mesa
|
| gptkbp:bfsLayer |
8
|